Ratings by Barclays (Lukas Shumway)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/4/2026 | Alpha Tau Medical Ltd. | DRTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/28/2026 | Sutro Biopharma | STRO | New Coverage | Overweight (N/A) |
27.38 (20.82) |
-23.96% | Details | |
| 5/28/2026 | Immunome Inc. | IMNM | New Coverage | Overweight (N/A) |
21.91 (27.07) |
23.55% | Details | |
| 5/28/2026 | Cellectis | CLLS | New Coverage | Overweight (N/A) |
3.67 (3.30) |
-10.08% | Details | |
| 5/28/2026 | Alpha Tau Medical Ltd. | DRTS | New Coverage | Overweight (N/A) |
10.37 (13.96) |
34.62% | Details |
